Clinical Trials
4 trialsNCT03703778 2025-05-06
READT
Chinese University of Hong Kong
Active not recruiting
NCT02588404 2024-12-10
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
Withdrawn
NCT05149131 2024-02-09
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer
Bayer
Completed
NCT02128334 2016-08-16
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Astellas Pharma Inc
Completed